sk&f 104078 has been researched along with quinoxalines in 5 studies
| Studies (sk&f 104078) | Trials (sk&f 104078) | Recent Studies (post-2010) (sk&f 104078) | Studies (quinoxalines) | Trials (quinoxalines) | Recent Studies (post-2010) (quinoxalines) |
|---|---|---|---|---|---|
| 29 | 0 | 0 | 9,887 | 625 | 3,095 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cawthorne, MA; Kelly, J; Roberts, SP; Sennitt, MV | 1 |
| Crosson, CE; DeVries, GW; Heath, AR; Potter, DE | 1 |
| Gleason, MM; Hieble, JP | 1 |
| Hieble, JP; Nichols, AJ; Ruffolo, RR; Sulpizio, AC; Willette, RN | 1 |
| Szreder, Z | 1 |
5 other study(ies) available for sk&f 104078 and quinoxalines
| Article | Year |
|---|---|
SK&F 104078, a post-junctionally selective alpha 2-adrenoceptor antagonist in the human saphenous vein in vitro.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Aged; Benzazepines; Brimonidine Tartrate; Humans; In Vitro Techniques; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Neuromuscular Junction; Norepinephrine; Quinoxalines; Saphenous Vein | 1992 |
Pharmacological evidence for heterogeneity of ocular alpha 2 adrenoceptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Benzazepines; Brimonidine Tartrate; Cats; Ciliary Body; Cyclic AMP; Dose-Response Relationship, Drug; Iris; Nictitating Membrane; Quinoxalines; Rabbits; Receptors, Adrenergic, alpha; Sympathetic Nervous System; Yohimbine | 1992 |
Ability of SK&F 104078 and SK&F 104856 to identify alpha-2 adrenoceptor subtypes in NCB20 cells and guinea pig lung.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Benzazepines; Brimonidine Tartrate; Cells, Cultured; Clonidine; Cricetinae; Dibenzazepines; Imidazoles; Indoles; Isoindoles; Lung; Mice; Neuroblastoma; Neurons; Oxymetazoline; Quinoxalines; Receptors, Adrenergic, alpha; Tritium; Tumor Cells, Cultured; Yohimbine | 1991 |
Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.
Topics: Adrenergic alpha-Antagonists; Animals; Benzazepines; Brimonidine Tartrate; Dogs; Guinea Pigs; Male; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Quinoxalines; Rats; Rats, Inbred Strains; Serotonin; Synaptic Transmission; Vasoconstriction | 1988 |
Do cardiovascular mechanisms participate in thermoregulatory activity of alpha 2-adrenoceptor agonists and antagonists in rabbits?
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Azepines; Benzazepines; Body Temperature; Body Temperature Regulation; Brimonidine Tartrate; Cold Temperature; Ear; Energy Metabolism; Fever; Hemodynamics; Lipopolysaccharides; Male; Pyrogens; Quinoxalines; Rabbits; Yohimbine | 1997 |